(Q33178730)

23 July 2017

The low potential for drug interactions with zanamivir (English)

1 reference

23 July 2017

1 reference

Daniel MJ

1

1 reference

23 July 2017

Barnett JM

series ordinal

2

1 reference

23 July 2017

Pearson BA

series ordinal

3

1 reference

23 July 2017

language of work or name

1 reference

1 January 1999

1 reference

Clinical Pharmacokinetics

23 July 2017

1 reference

23 July 2017

36 Suppl 1

1 reference

23 July 2017

41-50

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199936001-00005

23 July 2017

0 references

cites work

Differential oxidase activity of hepatic and pulmonary microsomal cytochrome P-450 isozymes after treatment with cytochrome P-450 inducers

1 reference

12 December 2020

Enzyme induction in the cytochrome P-450 system

1 reference

12 December 2020

Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms

1 reference

12 December 2020

Drug therapy. Binding of drugs to serum albumin (second of two parts)

1 reference

12 December 2020

Antihistaminics, local anesthetics, and other amines as antiviral agents

1 reference

12 December 2020

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

10.2165/00003088-199936001-00005

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference